Concentrated intravitreal amphotericin B in fungal endophthalmitis

Archives of Ophthalmology

Volumn 128, Issue 12, 2010, Pages 1546-1550

  Payne, John F ^a   Keenum, Deborah G ^b   Sternberg Jr , Paul ^c   Thliveris, Andrew ^d   Kala, Aaron ^a   Olsen, Timothy W ^a  

^a EMORY EYE CENTER   (United States)

^b BILLINGS CLINIC   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B DEOXYCHOLATE; CEFTAZIDIME; CLINDAMYCIN; STEROID; VANCOMYCIN;

ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CAPSULOTOMY; CASE REPORT; CATARACT; CATARACT EXTRACTION; CHILD; CORNEA PERFORATION; CYTOLOGY; DRUG EFFICACY; DRUG OVERDOSE; ECHOGRAPHY; EPIRETINAL MEMBRANE; EYE PAIN; EYE TOXICITY; FUNGAL ENDOPHTHALMITIS; FUNGEMIA; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LASER COAGULATION; LENSECTOMY; MALE; MEDICAL RECORD REVIEW; NEODYMIUM LASER; OPERATING ROOM; OPHTHALMOSCOPY; PARACENTESIS; PERIMETRY; POSTOPERATIVE INFLAMMATION; PRIORITY JOURNAL; RETINA DETACHMENT; SCHOOL CHILD; SCLERA BUCKLING PROCEDURE; SUBRETINAL FLUID; TREATMENT DURATION; TREATMENT RESPONSE; URETER OBSTRUCTION; VISUAL ACUITY; VITRECTOMY; VITREORETINOPATHY; VITREOUS BIOPSY; VITREOUS DISEASE; VITREOUS OPACITY;

AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CATARACT; CHILD; DEOXYCHOLIC ACID; DRUG COMBINATIONS; ENDOPHTHALMITIS; EYE INFECTIONS, FUNGAL; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; MYCOSES; RETINAL DETACHMENT; RETROSPECTIVE STUDIES; VISUAL ACUITY; VITREOUS BODY;

EID: 78650156330     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.305     Document Type: Article

References (20)

1. Pflugfelder SC, Flynn HW Jr. Infectious endophthalmitis. Infect Dis Clin North Am. 1992;6(4):859-873.
2. Gao H, Pennesi ME, Shah K, et al. Intravitreal voriconazole: an electroretinographic and histopathologic study. Arch Ophthalmol. 2004;122(11):1687-1692. (Pubitemid 39473415)
3. Flynn HW Jr. The clinical challenge of endogenous endophthalmitis. Retina. 2001; 21(6):572-574.
4. Chakrabarti A, Shivaprakash MR, Singh R, et al. Fungal endophthalmitis: fourteen years' experience from a center in India. Retina. 2008;28(10):1400- 1407.
5. Cannon JP, Fiscella R, Pattharachayakul S, et al. Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model. Invest Ophthalmol Vis Sci. 2003;44(5):2112-2117. (Pubitemid 36520306)
6. Wykoff CC, Flynn HW Jr, Miller D, Scott IU, Alfonso EC. Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology. 2008; 115(9):1501-1507.
7. Doft BH, Weiskopf J, Nilsson-Ehle I, Wingard LB Jr. Amphotericin clearance in vitrectomized versus nonvitrectomized eyes. Ophthalmology. 1985;92(11): 1601-1605. (Pubitemid 16203728)
8. Axelrod AJ, Peyman GA, Apple DJ. Toxicity of intravitreal injection of amphotericin B. Am J Ophthalmol. 1973;76(4):578-583.
9. Souri EN, Green WR. Intravitreal amphotericin B toxicity. Am J Ophthalmol. 1974; 78(1):77-81.
10. Foster JBT, Almeda E, Littman ML, Wilson ME. Some intraocular and conjunctival effects of amphotericin B in man and in the rabbit. AMA Arch Ophthalmol. 1958;60(4, pt 1):555-564.
11. Green WR, Bennett JE, Goos RD. Ocular penetration of amphotericin B: a report of laboratory studies and a case report of postsurgical cephalosporium endophthalmitis. Arch Ophthalmol. 1965;73:769-775.
12. Barza M, Baum J, Tremblay C, Szoka F, D'Amico DJ. Ocular toxicity of intravitreally injected liposomal amphotericin B in rhesus monkeys. Am J Ophthalmol. 1985;100(2):259-263. (Pubitemid 15240586)
13. Tremblay C, Barza M, Szoka F, Lahav M, Baum J. Reduced toxicity of liposome-associated amphotericin B injected intravitreally in rabbits. Invest Ophthalmol Vis Sci. 1985;26(5):711-718. (Pubitemid 15067812)
14. Bond CA, Raehl CL, Franke T. Medication errors in United States hospitals. Pharmacotherapy. 2001;21(9):1023-1036. (Pubitemid 32807863)
15. LaPointe NMA, Jollis JG. Medication errors in hospitalized cardiovascular patients. Arch Intern Med. 2003;163(12):1461-1466. (Pubitemid 36758919)
16. Kohn LT, Corrigan JM, Donaldson MS, eds. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000. http://books .nap.edu/openbook.php?record-id=9728&page=1. Accessed September 18, 2009.
17. Bates DW, Cullen DJ, Laird N, et al; ADE Prevention Study Group. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274(1):29-34.
18. Leape LL, Bates DW, Cullen DJ, et al; ADE Prevention Study Group. Systems analysis of adverse drug events. JAMA. 1995;274(1):35-43.
19. Shamliyan TA, Duval S, Du J, Kane RL. Just what the doctor ordered: review of the evidence of the impact of computerized physician order entry system on medication errors. Health Serv Res. 2008;43(1, pt 1):32-53. (Pubitemid 351601525)
20. Aspden P, Wolcott J, Bootman JL, Cronenwett LR, eds. Preventing Medication Errors. Washington, DC: National Academy Press; 2007.http://books. nap.edu /openbook.php?record-id=11623&page=1. Accessed September 18, 2009.